About C3i
Expertise in Cell and Gene Therapies, based out of Montreal QC and Toronto ON.
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Montreal, Québec
- Founded
- 2016
- Company type
- Nonprofit
C3i, is a full-service CDMO in Cell & Gene therapy, offering in-house services from, process development to commercial GMP manufacturing, Qc analytical development of tests and testing, biomarker development, immune monitoring, and CRO. We manufacture for Canada, US, and Europe
Operating in Montreal, Canada, C3i offers an integrated structure for the development, translation and commercialisation of these ground breaking therapies.
Offer our clients a "one-stop-shop" solution for the development, translation, and commercialization of their products: Our services - GMP Manufacturing Unit for Cell and Gene therapies - in-house testing Qc, Biomarker-Diagnostic and test development - Clinical Research offering KOLs, protocol development, and Key patient access - Investment & support for innovative companies
Specialties
- Cancer Immunotherapy
- Biomarkers
- Diagnostics
- cGMP Cell Manufacturing
- Innovation
- Commercialisation
- Clinical Research
- Networking
- regenerative medicine
- Stem cells
- Oncology
- and Cell and Gene Therapy
Company locations
Hôpital Maisonneuve-Rosemont, Pavillon Rachel Tourigny, 5415 Boulevard de l'Assomption, Montreal, Québec H1T 2M4, CA
101 College St., 8th floor MaRS South Tower, Mars Discovery District, Toronto, Ontario M5G 1L7, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
On LinkedIn
- Followers
- 5,723
- People linked to this company
- 87
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.